Robert M Wenham Selected Research

Robert M Wenham Research Topics

Disease

59	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 08/2002
46	Neoplasms (Cancer) 05/2024 - 01/2008
11	Ovarian Epithelial Carcinoma 12/2023 - 12/2004
8	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 01/2009
5	Carcinoma (Carcinomatosis) 01/2022 - 06/2013
4	Disease Progression 01/2023 - 10/2014
3	Fallopian Tube Neoplasms 10/2022 - 08/2014
3	Anemia 08/2021 - 10/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2004
3	Prostatic Neoplasms (Prostate Cancer) 08/2013 - 02/2005
2	Inflammation (Inflammations) 07/2023 - 06/2023
2	Fatigue 06/2023 - 07/2013
2	Vascular System Injuries 08/2021 - 07/2009
2	Vomiting 01/2020 - 01/2017
2	Infections 01/2019 - 10/2002
2	Neutropenia 01/2019 - 10/2014
2	Endometriosis 10/2018 - 12/2004
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Cholangiocarcinoma 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Wounds and Injuries (Trauma) 08/2021
1	Venous Thromboembolism 08/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2020
1	Diarrhea 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Vulvar Neoplasms (Vulvar Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 05/2024 - 07/2013
12	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 10/2012
10	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 10/2012
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2020
6	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 01/2008
4	Bevacizumab (Avastin)FDA Link 10/2022 - 07/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
4	niraparibIBA 12/2019 - 08/2013
4	trebananibIBA 01/2019 - 10/2014
4	MicroRNAs (MicroRNA)IBA 10/2016 - 01/2008
3	AntigensIBA 01/2023 - 01/2021
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 01/2012
2	PafolacianineIBA 10/2023 - 10/2019
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
2	Gemcitabine FDA Link 01/2020 - 07/2012
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2019 - 08/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 01/2017
2	Progestins (Progestagens)IBA 01/2019 - 12/2013
2	1-dodecylpyridoxal (PLD)IBA 01/2017 - 10/2014
2	liposomal doxorubicin (Doxil)FDA Link 01/2017 - 10/2014
2	Sorafenib (BAY 43-9006)FDA Link 08/2014 - 01/2009
2	Docetaxel (Taxotere)FDA Link 03/2014 - 07/2013
2	Insulin (Novolin)FDA Link 07/2007 - 02/2005
2	CytosineIBA 07/2007 - 02/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2004 - 03/2003
1	cediranib (AZD2171)IBA 05/2024
1	TabletsIBA 05/2024
1	olaparibIBA 05/2024
1	sapanisertibIBA 11/2023
1	serabelisibIBA 11/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2023
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2023
1	Type I Tumor Necrosis Factor ReceptorsIBA 06/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	Folic Acid AntagonistsIBA 01/2023
1	Viral DNAIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	CreatinineIBA 01/2023
1	farletuzumabIBA 01/2023
1	delta proteinIBA 10/2022
1	navicixizumabIBA 10/2022
1	Odorant Receptors (Odorant Receptor)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Caveolin 1IBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	polymeric IgAIBA 01/2021
1	adavosertibIBA 01/2020
1	ralimetinibIBA 01/2020
1	Platelet Factor 3 (PF 3)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020

Therapy/Procedure

20	Therapeutics 04/2024 - 01/2009
19	Drug Therapy (Chemotherapy) 12/2023 - 10/2011
4	Salpingo-oophorectomy 01/2020 - 01/2017
3	Cytoreduction Surgical Procedures 10/2023 - 07/2015
3	Immunotherapy 01/2022 - 01/2017
3	Lymph Node Excision (Lymph Node Dissection) 08/2021 - 07/2009
3	Radiotherapy 10/2020 - 01/2020
2	Palliative Care (Palliative Therapy) 06/2023 - 01/2017
2	Chemoradiotherapy 10/2020 - 01/2020
2	Adjuvant Chemotherapy 01/2019 - 10/2018
2	Pelvic Exenteration 10/2018 - 11/2009
2	Chemoprevention 02/2009 - 01/2009
1	Blood Transfusion (Blood Transfusions) 08/2021
1	Sutures (Suture) 08/2021
1	Brachytherapy 10/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020